The Immunoexpressions and Prognostic Significance of Inhibin Alpha and Beta Human Chorionic Gonadotrophins (hCG) in Breast Carcinomas
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Purpose: Pregnancy and hCG treatments are considered essential for inhibiting breast cancer. The effect of hCG is accompanied by the synthesis of inhibin, a transforming growth factor involved in cell differentiation and proliferation. Inhibin is considered a tumor suppressor, but its role in the breast is unclear. The aim of this study was to determine the frequency and tissue distribution of the expressions of inhibin-α and β-hCG in breast cancer, and their prognostic relevance with other biological parameters. Materials and Methods: 334 of formalin-fixed, paraffin embedded tissue blocks were selected, and then immunostained for inhibin-α and β-hCG. The inhibin-α expression was compared with those of β-hCG, ER, PR and HER-2/neu, as well as the tumor characteristics and recurrences. Results: Inhibin-α and β-hCG were expressed in 87 (26.0%) and 44 cases (13.2%), respectively. Inhibin-α was found in 25.1% of infiltrating ductal carcinomas (67/267), 26.7% of intraductal carcinomas (8/30), 33.3% of lobular tumors (3/9), 80.0% of apocrine carcinomas (4/5) and 21.7% of the other types (5/23). Inhibin-α was correlated with β-hCG (p＜0.0001), PR (p=0.010) and HER-2/ neu (p=0.021). HCG was focally expressed in the cytoplasm of the conventional types, but the apocrine type displayed diffusely intense cytoplasmic staining, which correlated with histological tumor types (p＜0.001). Conclusion: Inhibin was significantly correlated with the expressions of hCG, PR and HER-2/neu. Therefore, it might be a useful marker in the prevention and hormonal treatment of breast cancer, such as hCG and progesterone. HCG was expressed significantly higher in the apocrine type than the conventional types, suggesting it can be a useful adjunct in differentiating other cancer types.
참고문헌 (19)
- "Hormonal approach to breast cancer prevention", 77(s34), pp.1~6 (2000)
- "Transforminggrowth factor-β superfamily: evaluation as breast cancerbiomarkers and preventive agents.", 4, pp.165~82 (2004)
- "Human mammary gland and breast carcinoma containimmunoreactive inhibin", activin subunits:evidence for asecretion into cystic fluid, 1999, pp.141, 190~4
- "Inhibin and activin:their roles in ovariantumorigenesis and their diagnostic utility in surgicalpathology practice", 7, pp.29~38 (1999)
- "Inhibins and ovarian cancer", 225, pp.65~71 (2004)
- "Activin, inhibin and the human breast.", 225(l), pp.77~82 (2004)
- "Human chorionic gonadotrophin-β transcripts correlatewith progesterone receptor values in breast carcinomas", 24, pp.33~41 (2000)
- "Proteinbiomarkers for breast cancer prevention", 13, pp.307~17 (2004)
- "Pathological prognostic factors in breastcancer The value of histological grade in breast cancer experience from a large study with long-term follow-up", pp.403~10 (1991)
- "The spectrum of apocrine lesions ofthe breast", 11, pp.1~9 (2004)
- "Reevaluationof inhibin alpha subunit as a tumour suppressor inprostate cancer", 225, pp.73~6 (2004)
- "Immunohistochemicalexpression of subunit beta HCG in breast cancer", 13, pp.461~6 (1992)
- "Immunohistologicallocalization of beta-HCG in breast carcinomas", pp.679~84 (1984)
- "Expression of topoisomerase II-α and c-erbB-2 in breastcancer", 5, pp.135~41 (2002)
- "Adenocarcinomas of varioussites may exhibit immunoreactivity with anti-inhibin antibodies", 35, pp.216~20 (1999)
- "Development of an inhibin alpha subunitELISA with broad specificity", 180, pp.79~86 (2001)
- "Betaglycan binds inhibin and can mediatefunctional antagonism of activin signaling", 404, pp.411~4 (2000)
- "Human chorionicgonadotropin expression in lung", and renal carci(mas), pp.282~5 (1988)
- "Effect of human chorionicgonadotrophin in the gene expression profile of MCF-7cells", 24, pp.399~407 (2004)